Latest News

Evotec and Takeda enter drug discovery deal

Ecotec’s Hamburg headquarters. Evotec in 2003 had already have a drug discovery alliance with Takeda in ALzheimer. © Evotec SE


Evotec SE and Takeda Pharmaceutical Company Ltd have entered a strategic drug discovery collaboration potentially worth $850m.

Under the agreement, Evotec will develop at least five small molecule discovery programmes against targets identified by Takeda in oncology, gastroenterology, neuroscience and rare diseases. Takeda will have the option to assume responsibility at lead series and upon Evotec delivering a pre-clinical candidate.

Under the terms of the collaboration, Takeda will pay Evotec an undiclosed upfront fee to get access to its platforms. Additionally, Evotec is eligible to receive pre-clinical, clinical, and commercial milestones that can total in excess of $170 m per programme as well as tiered royalties on future sales.

Illumina embraces Roche

Just in time for the start of the JP Morgan conference, Roche and Illumina, the competitors in the emerging market of NGS-based cancer patient...

Healx Ltd raises $56m in Series B financing

The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new investors. Existing investors from a US$10m...

Belgian start-up takes fight on neuropathies

„Augustine was a famous patient of famous French neurologist Jean-Martin Charcot‚” Ward Capoen, Principal at V-Bio Ventures, told...

4SC expands domatinostat combo testing

In an investigator-initiated Phase Ib study (DONIMI) at NKI, 40 patients with melanoma will be enrolled  before surgery (neoadjuvant setting) to...

Merry Christmas and a Happy New Year

BioNTech acquires Neon at cheapest for $67m

According to the merger agreement, BioNTech AG will acquire Neon Therapeutics Inc in an all-stock transaction that will close in Q2/2020 and is...

Cell transdifferentiation specialist Mogrify Ltd raises US$16m

The company has developed a unique scalable technology for direct cellular transdifferentiation, based on the FANTOM5 dataset of human regulatory...